Studying how asthma affects people in everyday care
Observes people with asthma to describe their symptoms, treatment and daily burden.
Plain-language title generated from the registry record
Registry title: A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
Key facts
- Where
- Altamonte Springs, Ann Arbor, Asheville, Bellingham, Bessemer, Boca Raton, Brandon, California City, Chandler, Chicago, Columbia, Columbus, Cortland, Dallas, El Paso, Gastonia, Greenacres City, Greenville, Houston, Hurst, La Palma, Lexington, Lima, Los Angeles, Mesa, Miami, Miami Gardens, Miami Lakes, Missoula, New Windsor, New York, Newport Beach, North Miami Beach, Palm Springs, Papillion, Pasadena, Pittsburgh, Plantation, Port Saint Lucie, Rock Hill, Rockville, Scottsdale, Sewell, Sun City, Tamarac, Tampa, Tarzana, Tennessee City, Toledo, Tomball, Walnut Creek, and West Palm Beach, United StatesSee the 63 sites
- Phase
- Phase 4
Where in United States
- Cornerstone Research Institute, LLC - Site Number: 840152Altamonte Springs, United StatesNo longer taking part
- University of Michigan - Ann Arbor - Site Number: 840140Ann Arbor, United StatesTaking people
- Allergy Partners of Western North Carolina - Site Number: 840131Asheville, United StatesNo longer taking part
- Bellingham Asthma, Allergy & Immunology Clinic - Site Number: 840138Bellingham, United StatesNo longer taking part
- Trinity Clinical Research, LLC - Bessemer - Site Number: 840150Bessemer, United StatesTaking people
- 3SYNC Research - Boca Raton - Site Number: 840148Boca Raton, United StatesNo longer taking part
- BrandonBrandon, United StatesNo longer taking part
- FOMAT - Huntington Asthma & Allergy Center - Site Number: 840158California City, United StatesNo longer taking part
- ChandlerChandler, United StatesNo longer taking part
- Next Innovation Clinical Research - Chicago - Site Number: 840159Chicago, United StatesNo longer taking part
- Columbia Medical Practice - Site Number: 840172Columbia, United StatesTaking people
- The Allergy Center at Brookstone - Site Number: 840114Columbus, United StatesNo longer taking part
- Finger Lakes Medical Research, PLLC - Site Number: 840155Cortland, United StatesNo longer taking part
- Southwest Family Medicine Associates - Site Number: 840126Dallas, United StatesNo longer taking part
- El Paso Pulmonary Association (EPPA) - West El Paso - Site Number: 840108El Paso, United StatesNo longer taking part
- Clinical Research of Gastonia (CRG) - Site Number: 840160Gastonia, United StatesNo longer taking part
- Finlay Medical Research - Site Number: 840107Greenacres City, United StatesNo longer taking part
- East Carolina University Physicians - Pulmonary and Critical Care Medicine - Site Number: 840142Greenville, United StatesTaking people
- HoustonHouston, United StatesNo longer taking part
- Pioneer Research Solutions - Site Number: 840104Houston, United StatesNo longer taking part
- Lumi Research - Hurst - Site Number: 840164Hurst, United StatesNo longer taking part
- La PalmaLa Palma, United StatesNo longer taking part
- Bluegrass Allergy Care - Lexington - Site Number:840112Lexington, United StatesNo longer taking part
- LimaLima, United StatesNo longer taking part
- Los AngelesLos Angeles, United StatesNo longer taking part
- Del Sol Research Management, LLC - Mesa - Site Number: 840123Mesa, United StatesNo longer taking part
- MiamiMiami, United StatesNo longer taking part
- MiamiMiami, United StatesNo longer taking part
- Care Research Inc. - Site Number: 840103Miami, United StatesNo longer taking part
- Correa Research Center, Inc. - Site Number: 840141Miami, United StatesNo longer taking part
- D&H National Research Centers INC - Site Number: 840128Miami, United StatesNo longer taking part
- Finlay Medical Research - Miami - Site Number: 840110Miami, United StatesNo longer taking part
- L&A Morales Healthcare, Inc - Site Number: 840102Miami, United StatesNo longer taking part
- Research Institute Of South Florida - Site Number: 840149Miami, United StatesNo longer taking part
- Valencia Medical & Research Center, Corp - Site Number: 840153Miami, United StatesNo longer taking part
- Pro Care Research Center - Site Number: 840143Miami Gardens, United StatesNo longer taking part
- 3SYNC Research - Miami Lakes - Site Number: 840146Miami Lakes, United StatesNo longer taking part
- Deluxe Health Center - Site Number: 840117Miami Lakes, United StatesNo longer taking part
- MedQuest Translation Sciences, LLC - Site Number: 840162Miami Lakes, United StatesNo longer taking part
- Montana Medical Research - Site Number: 840137Missoula, United StatesNo longer taking part
- Mid Hudson Medical Research, PLLC - Site Number: 840139New Windsor, United StatesNo longer taking part
- Icahn School of Medicine at Mount Sinai - Center for Advanced Medicine - Site Number: 840119New York, United StatesNo longer taking part
- Newport Native MD, Inc. - Site Number: 840101Newport Beach, United StatesNo longer taking part
- North Miami BeachNorth Miami Beach, United StatesNo longer taking part
- CTMD Research, Inc - Site Number: 840147Palm Springs, United StatesNo longer taking part
- Primary Clinical Research, LLC - Papillion - Site Number: 840168Papillion, United StatesNo longer taking part
- PasadenaPasadena, United StatesNo longer taking part
- Allergy and Clinical Immunology Associates - Site Number: 840127Pittsburgh, United StatesNo longer taking part
- Edward Jenner Research Group, LLC - Site Number: 840169Plantation, United StatesNo longer taking part
- Mark J. Pamer D.O., LLC - Site Number: 840121Port Saint Lucie, United StatesNo longer taking part
- Clinical Research of Rock Hill - Site Number: 840115Rock Hill, United StatesNo longer taking part
- Velocity Clinical Research - Rockville - Site Number: 840163Rockville, United StatesNo longer taking part
- Orso Health - Scottsdale - Site Number: 840133Scottsdale, United StatesTaking people
- MedCorps Asthma and Pulmonary Specialists LLC - Sewell - Site Number: 840136Sewell, United StatesNo longer taking part
- Sun City Clinical Trials - Elite - Site Number: 840120Sun City, United StatesNo longer taking part
- TBC Research Corp - Site Number: 840132Tamarac, United StatesNo longer taking part
- Avita Clinical Research - Tampa - Site Number: 840125Tampa, United StatesNo longer taking part
- Valiance Clinical Research (JPJ Research) - Site Number: 840135Tarzana, United StatesNo longer taking part
- Allergy Associates, PA dba Allergy, Asthma and Sinus Center - Site Number: 840144Tennessee City, United StatesNo longer taking part
- Toledo Institute of Clinical Research Inc - Site Number: 840105Toledo, United StatesNo longer taking part
- DM Clinical - Tomball - Site Number: 840130Tomball, United StatesNo longer taking part
- Clinical Research of California - Site Number: 840145Walnut Creek, United StatesNo longer taking part
- Palm Beach Medical & Research Center, Inc. - Site Number: 840165West Palm Beach, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Sanofi
- Trial code
- NCT07556159EU 2025-524916-13-00
- Record updated
- 5 November 2026
- Original description
The main aim of the study to describe the characteristics of participants with asthma across the spectrum of disease severity, including sociodemographic and clinical characteristics, treatment and disease burden, biomarkers, and both disease-specific and generic health-related quality of life.Read full original descriptionShow less
A Hybrid Cross-sectional and Prospective Study to Assess Patient Characteristics, Disease Burden, Disease Control, Phenotypes, Endotypes, and Outcomes in a Real-world Setting in Patients With Asthma
The main aim of the study to describe the characteristics of participants with asthma across the spectrum of disease severity, including sociodemographic and clinical characteristics, treatment and disease burden, biomarkers, and both disease-specific and generic health-related quality of life.
The study consists of two parts: a cross-sectional study, and a prospective follow-up evaluate changes in disease trajectories in participants with asthma.
Inclusion: Applicable for Part 1 participants:; Age 6 years and older, at the time of signing the informed consent; Physician diagnosis of asthma for at least 12 months; Existing treatment with low, medium, or high dose ICS and other asthma therapies as reflected in GINA 2-5 steps; Participant or legally authorized representative (where applicable) has consented to participate; Applicable for Part 2 participants:; Age 18 years and older, at the time of signing the informed consent; Physician diagnosis of asthma for at least 12 months; Existing treatment with low or medium ICS and other asthma therapies as reflected in GINA 2-4 steps; Participant or legally authorized representative (where applicable) has consented to participate; Participants must meet the criteria for at least one of the cohorts below:; Asthma control cohorts; ACQ-5 >= 1.5; ACQ-5 < 1.5 (B) Type-2 biomarker cohorts; Elevated T2 biomarkers (B1: Type-2-high cohort); Low T2 biomarkers (B2: Type-2-low cohort); Participants are excluded from the study if any of the following criteria apply (applicable for both Part 1 and Part 2 participants):; Current diagnosis of chronic obstructive pulmonary disease (COPD) or congestive heart failure; Participants with moderate/severe cognitive impairment; Participants with moderate/severe cardiac disease; Participants on immunosuppressive medication for a chronic condition; Participation in other interventional and noninterventional clinical study (currently or in the past 3 months); The above information is not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.